首页> 外文期刊>Journal of orthopaedic research >Low-dose BMP-2 and MSC dual delivery onto coral scaffold for critical-size bone defect regeneration in sheep
【24h】

Low-dose BMP-2 and MSC dual delivery onto coral scaffold for critical-size bone defect regeneration in sheep

机译:低剂量BMP-2和MSC双重输送到珊瑚支架上,用于绵羊中的临界大小骨缺损再生

获取原文
获取原文并翻译 | 示例
           

摘要

Tissue-engineered constructs (TECs) combining resorbable calcium-based scaffolds and mesenchymal stem cells (MSCs) have the capability to regenerate large bone defects. Inconsistent results have, however, been observed, with a lack of osteoinductivity as a possible cause of failure. This study aimed to evaluate the impact of the addition of low-dose bone morphogenetic protein-2 (BMP-2) to MSC-coral-TECs on the healing of clinically relevant segmental bone defects in sheep. Coral granules were either seeded with autologous MSCs (bone marrow-derived) or loaded with BMP-2. A 25-mm-long metatarsal bone defect was created and stabilized with a plate in 18 sheep. Defects were filled with one of the following TECs: (i) BMP (n=5); (ii) MSC (n=7); or (iii) MSC-BMP (n=6). Radiographic follow-up was performed until animal sacrifice at 4 months. Bone formation and scaffold resorption were assessed by micro-CT and histological analysis. Bone union with nearly complete scaffold resorption was observed in 1/5, 2/7, and 3/6 animals, when BMP-, MSC-, and MSC-BMP-TECs were implanted, respectively. The amount of newly formed bone was not statistically different between groups: 1074mm(3) [970-2478mm(3)], 1155mm(3) [970-2595mm(3)], and 2343mm(3) [931-3276mm(3)] for BMP-, MSC-, and MSC-BMP-TECs, respectively. Increased scaffold resorption rate using BMP-TECs was the only potential side effect observed. In conclusion, although the dual delivery of MSCs and BMP-2 onto a coral scaffold further increased bone formation and bone union when compared to single treatment, results were non-significant. Only 50% of the defects healed, demonstrating the need for further refinement of this strategy before clinical use. (c) 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 35:2637-2645, 2017.
机译:组织工程构建体(TECS)组合可再吸收的钙基支架和间充质干细胞(MSCs)具有再生大骨缺陷的能力。然而,已经观察到不一致的结果,缺乏骨诱导性作为可能的失败原因。本研究旨在评估将低剂量骨形态发生蛋白-2(BMP-2)添加到MSC-珊瑚 - TECS对绵羊临床相关节段骨缺损的愈合的影响。珊瑚颗粒用自体MSC(骨髓衍生)播种或用BMP-2加载。用18羊的板坯产生和稳定25mm长的跖骨缺损。缺陷填充有以下一个TECS之一:(i)bmp(n = 5); (ii)MSC(n = 7);或(iii)MSC-BMP(n = 6)。射线照相随访是在4个月内进行动物牺牲。通过微型CT和组织学分析评估骨形成和支架再吸收。当分别植入BMP-,MSC-和MSC-BMP-TECS时,在1/5,2 / 7和3/6动物中观察到具有几乎完全脚手架的骨联合会。新形成的骨的量在组之间没有统计学不同:1074mm(3)[970-2478mm(3)],1155mm(3)[970-2595mm(3)]和2343mm(3)[931-3276mm(3 )]对于BMP - ,MSC和MSC-BMP-TECS分别。使用BMP-TECS增加了脚手架吸收率的增加是观察到的唯一潜在的副作用。总之,尽管与单处治疗相比,MSCs和BMP-2的双重递送进一步增加骨形成和骨头愈合,但结果是非显着的。只有50%的缺陷愈合,表明在临床使用前进一步改进了这种策略。 (c)2017年骨科研究会。由Wiley期刊出版,Inc.J Orthop Res 35:2637-2645,2017。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号